Citation Tools

Original research
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

Download to a citation manager

Cite this article as:
Lheureux S, Matei DE, Konstantinopoulos PA, et al
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer